
|Articles|January 1, 2003
Advances in macular surgery helpful for pathologic myopia disorders
Author(s)Julia Talsma
Orlando-Recent advances in macular surgery are now making it possible to treat the various disorders associated with pathologic myopia, according to Yasuo Tano, MD, who delivered the Edward Jackson Memorial Lecture during the opening session of the American Academy of Ophthalmology annual meeting.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves carbachol–brimonidine eye drop for presbyopia following phase 3 BRIO trials
2
Opus Genetics launches phase 1/2 MERTK gene therapy trial
3
FDA approves NDA labeling supplement allowing re-administration of iDose TR
4
FDA Type C meeting supports phase 2b/3 pathway for urcosimod in neuropathic corneal pain
5



























